Outcome of Transplantation for Acute Lymphoblastic Leukemia in Children With Down Syndrome

被引:23
|
作者
Hitzler, Johann K. [1 ]
He, Wensheng [2 ]
Doyle, John [1 ]
Cairo, Mitchell [3 ]
Camitta, Bruce M. [4 ]
Chan, Ka Wah [5 ]
Diaz Perez, Miguel A. [6 ]
Fraser, Christopher [7 ]
Gross, Thomas G. [8 ]
Horan, John T. [9 ]
Kennedy-Nasser, Alana A. [10 ]
Kitko, Carrie [11 ]
Kurtzberg, Joanne [12 ]
Lehmann, Leslie [13 ]
O'Brien, Tracey [14 ]
Pulsipher, Michael A. [15 ]
Smith, Franklin O. [16 ]
Zhang, Mei-Jie [2 ]
Eapen, Mary [2 ]
Carpenter, Paul A. [17 ]
机构
[1] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA
[5] Texas Transplant Inst, San Antonio, TX USA
[6] Hosp Nino Jesus, Madrid, Spain
[7] Royal Childrens Hosp, Herston, Qld, Australia
[8] Nationwide Childrens Hosp, Columbus, OH USA
[9] Childrens Healthcare Atlanta Egleston, Atlanta, GA USA
[10] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Duke Univ, Durham, NC USA
[13] Dana Farber Canc Inst, Boston, MA 02115 USA
[14] Sydney Childrens Hosp, Sydney, NSW, Australia
[15] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA
[16] Univ Cincinnati, Inst Canc, Cincinnati, OH USA
[17] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
acute lymhoblastic leukemia; Down syndrome; hematopoietic stem cell transplantation; pediatric; relapse; trisomy; 21; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; TOXICITY; FAILURE; REGIMEN; RELAPSE;
D O I
10.1002/pbc.24918
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than expected for children with DS-ALL (54%) than for non-DS ALL. These data suggest leukemic relapse rather than transplant toxicity is the most important cause of treatment failure. Advancements in leukemia control are especially needed for improvement in HCT outcomes for DS-ALL. Pediatr Blood Cancer 2014;61:1126-1128. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1126 / 1128
页数:3
相关论文
共 50 条
  • [31] Genome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
    Brown, Austin L.
    de Smith, Adam J.
    Scheurer, Michael E.
    Kallsen, Noah A.
    Peyton, Shanna A.
    Davies, Gareth E.
    Ehli, Erik A.
    Zwick, Michael E.
    Winick, Naomi
    Maloney, Kelly
    Angiolillo, Anne L.
    Schore, Reuven
    Burke, MIchael M.
    Salzer, Wanda L.
    Heerema, Nyla A.
    Carroll, Andrew J.
    Borowitz, Michael J.
    Wood, Brent L.
    Carroll, William L.
    Raetz, Elizabeth A.
    Feingold, Elanor
    Sherman, Stephanie L.
    Yang, Wenjian
    Devidas, Meenakshi
    Walsh, Kyle
    DeWan, Andrew T.
    Pombo-de-Oliveira, Maria S.
    Taub, Jeffrey W.
    Sinnett, Daniel
    Healy, Jasmine
    Birch, Jillian M.
    Barcellos, Lisa F.
    Hansen, Helen
    Smirnov, Ivan
    Mullighan, Charles G.
    Hunger, Stephen P.
    Pui, Ching-Hon
    Loh, Mignon
    Wiemels, Joe L.
    Ma, Xiaomei
    Metayer, Catherine
    Mueller, Beth A.
    Relling, Mary V.
    Yang, Jun J.
    Lupo, Philip J.
    Rabin, Karen R.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome
    Athale, Uma
    Sutradhar, Rinku
    Breakey, Vicky R.
    Li, Qing
    Bassal, Mylene
    Gibson, Paul
    Patel, Serina
    Wheaton, Laura
    Pole, Jason D.
    Mittman, Nicole
    Pechlivanoglou, Petros
    Gupta, Sumit
    PEDIATRIC BLOOD & CANCER, 2022, 69 (10)
  • [33] The Effect of Hematopoietic Stem Cell Transplantation on Treatment Outcome in Children with Acute Lymphoblastic Leukemia
    Ju, Hee Young
    Lee, Na Hee
    Yi, Eun Sang
    Choi, Young Bae
    Kim, So Jin
    Hyun, Ju Kyung
    Cho, Hee Won
    Lee, Jae Kyung
    Lee, Ji Won
    Sung, Ki Woong
    Koo, Hong Hoe
    Yoo, Keon Hee
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 240 - 249
  • [34] XYY syndrome in children with acute lymphoblastic leukemia
    Sandlund, JT
    Krance, R
    Pui, CH
    Hancock, M
    Crist, WM
    Filatov, LV
    Raimondi, SC
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 28 (01): : 6 - 8
  • [35] BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
    T D Buitenkamp
    R Pieters
    M Zimmermann
    V de Haas
    S M Richards
    A J Vora
    C D Mitchell
    C Schwab
    C J Harrison
    A V Moorman
    M M van den Heuvel-Eibrink
    C M Zwaan
    Leukemia, 2013, 27 : 251 - 252
  • [36] BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
    Buitenkamp, T. D.
    Pieters, R.
    Zimmermann, M.
    de Haas, V.
    Richards, S. M.
    Vora, A. J.
    Mitchell, C. D.
    Schwab, C.
    Harrison, C. J.
    Moorman, A. V.
    van den Heuvel-Eibrink, M. M.
    Zwaan, C. M.
    LEUKEMIA, 2013, 27 (01) : 251 - 252
  • [37] Hematopoietic Cell Transplantation for Children with Acute Megakaryoblastic Leukemia without Down Syndrome
    Hama, Asahito
    Taga, Takashi
    Tomizawa, Daisuke
    Muramatsu, Hideki
    Hasegawa, Daiichiro
    Adachi, Souichi
    Yoshida, Nao
    Noguchi, Maiko
    Inoue, Masami
    Oakada, Keiko
    Koh, Katsuyoshi
    Atsuta, Yoshiko
    Ishida, Hiroyuki
    BLOOD, 2018, 132
  • [38] Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia
    Tomizawa, Daisuke
    Endo, Akifumi
    Kajiwara, Michiko
    Sakaguchi, Hirotoshi
    Matsumoto, Kimikazu
    Kaneda, Makoto
    Taga, Takashi
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [39] Management and Outcome of Children with Relapse of Acute Lymphoblastic Leukemia
    Bouterfas, N.
    Bouferoua, F.
    Oussaid, A. Mohand
    Dahmane, N.
    Boukhadouma, N.
    Benhalla, K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S453 - S454
  • [40] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.
    Rocha, JC
    Cheng, C
    Liu, W
    Kishi, S
    Das, S
    Cook, EH
    Sandlund, JT
    Rubnitz, J
    Ribeiro, RC
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2004, 104 (11) : 50A - 51A